Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 16965686 | HLA MATCHED (HLA-MATCHED) | hematological disease | NA | NA | NA | unclassified | |
| our present study was to explore the feasibility of allo-hsct by using haploid hla-matched donor in treatment for malignant hematological disease. | |||||||
| 16965686 | HLA (HLA) | hematological disease | NA | NA | NA | unclassified | |
| twenty-five patients with malignant hematological disease received allo-hsct with hla 2 or 3 antigen mismatched related donors. | |||||||
| 16965686 | HLA MATCHED (HLA-MATCHED) | hematological disease | NA | NA | NA | negation | |
| haploid hla-matched allo-hsct is a relatively efficient method for the treatment of patients with malignant hematological disease, who have no related matched donors. | |||||||
| 17008540 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| beyond hla: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. | |||||||
| 17029201 | HLA (HLA) | hematopoietic stem cell transplantation | Chinese | NA | NA | unclassified | |
| [genetic polymorphism of hla-cw locus in hematopoietic stem cell transplantation patient and donor population]. | |||||||
| 17041606 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | methotrexate | NA | unclassified | |
| low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin. | |||||||
| 17041606 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | methotrexate | NA | unclassified | |
| human leukocyte antigen (hla)-matched sibling donor hematopoietic stem cell transplantation (hsct) is available for only approximately 30% patients needing hsct. | |||||||
| 17100886 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | negation | |
| although the optimal donor for allogeneic hematopoietic stem cell transplantation (hsct) is a human leukocyte antigen-matched sibling, 75% of patients do not have a match, and alternatives are matched unrelated volunteers, unrelated umbilical cord blood units, and full-haplotype-mismatched family members. | |||||||
| 17124089 | HLA MATCHED (HLA-MATCHED) | cyclophosphamide | NA | fludarabine | NA | unclassified | |
| NA | |||||||
| 17124089 | HLA MATCHED (HLA-MATCHED) | cyclophosphamide | NA | fludarabine | NA | unclassified | |
| NA | |||||||
Copyright 2024